RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutation
Journal article published in 2020 by
Baptiste Le Calvez,
Yannick Le Bris 
,
Guillaume Herbreteau,
Bastien Jamet ,
Céline Bossard,
Benoit Tessoulin ,
Thomas Gastinne,
Béatrice Mahé,
Viviane Dubruille,
Nicolas Blin,
Chloé Antier,
Olivier Theisen,
Françoise Kraeber‐Bodéré,
Steven Le Gouill,
Marie C. Béné
and other authors.
,
Guillaume Herbreteau,
Bastien Jamet ,
Céline Bossard,
Benoit Tessoulin ,
Thomas Gastinne,
Béatrice Mahé,
Viviane Dubruille,
Nicolas Blin,
Chloé Antier,
Olivier Theisen,
Françoise Kraeber‐Bodéré,
Steven Le Gouill,
Marie C. Béné
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 